Word

XPANDOMER

Status

Pending

Status Code

681

Status Date

Thursday, March 14, 2024

Serial Number

97900361

Mark Type

4000

Filing Date

Friday, April 21, 2023

Published for Opposition

Tuesday, April 23, 2024

Trademark Owner History

Roche Molecular Systems, Inc.

Classifications

9 Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for DNA sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing DNA sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes

5 In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits comprised of reagents for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with DNA sequencing and genetic analysis

1 In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing DNA, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis

Trademark Events

Apr 3, 2024

Notification Of Notice Of Publication E-Mailed

Apr 3, 2024

Notification Of Notice Of Publication E-Mailed

Mar 13, 2024

Approved For Pub - Principal Register

Mar 13, 2024

Examiner's Amendment Entered

Mar 13, 2024

Notification Of Examiners Amendment E-Mailed

Mar 13, 2024

Examiners Amendment E-Mailed

Mar 13, 2024

Examiners Amendment -Written

Feb 21, 2024

Teas/Email Correspondence Entered

Feb 21, 2024

Correspondence Received In Law Office

Feb 21, 2024

Teas Response To Office Action Received

Dec 19, 2023

Notification Of Non-Final Action E-Mailed

Dec 19, 2023

Non-Final Action E-Mailed

Dec 19, 2023

Non-Final Action Written

Dec 18, 2023

Previous Allowance Count Withdrawn

Dec 12, 2023

Withdrawn From Pub - Og Review Query

Nov 28, 2023

Approved For Pub - Principal Register

Nov 22, 2023

Assigned To Examiner

May 17, 2023

New Application Office Supplied Data Entered

Apr 25, 2023

New Application Entered